Lacticaseibacillus rhamnosus R0011
Lacticaseibacillus rhamnosus R0011 is a well-studied probiotic strain with a research base spanning food technology, immunology, and gut health. In vitro studies have examined cytokine profiles in macrophage models in the context of immune regulation, and it has been investigated in combination with other lactobacilli in two randomized controlled trials — one in the context of adjunctive use in chronic rhinosinusitis and one in the context of antibiotic-associated diarrhea in healthy adults. Animal research has also explored interactions with gut microbiota composition. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 73 body-system-tagged papers that concern each system. Research coverage, not measured effect.
+3 more systems
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 30 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
86 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
Source →Probiotic secretomes and prebiotics modulate the adverse effects of polychlorinated biphenyls on in vitro intestinal outcomes· Open MIND · 2025
-
[2]
PMID 41821821 →Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study· Frontiers in Gastroenterology · 2023
-
[3]
PMID 35154018 →Probiotics Exhibit Strain-Specific Protective Effects in T84 Cells Challenged With Clostridioides difficile-Infected Fecal Water· Frontiers in Microbiology · 2022
-
[4]
PMID 36246229 →Lacticaseibacillus rhamnosus R0011 secretome attenuates Salmonella enterica serovar Typhimurium secretome-induced intestinal epithelial cell monolayer damage and pro-inflammatory mediator production in intestinal epithelial cell and antigen-presenting cell co-cultures· Frontiers in Microbiology · 2022
-
[5]
PMID 35889193 →Beneficial Shifts in Gut Microbiota by Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 in Alcoholic Hepatitis· Microorganisms · 2022
-
[6]
PMID 32238458 →Secretome-Mediated Interactions with Intestinal Epithelial Cells: A Role for Secretome Components from Lactobacillus rhamnosus R0011 in the Attenuation of Salmonella enterica Serovar Typhimurium Secretome and TNF-α–Induced Proinflammatory Responses· The Journal of Immunology · 2020
-
[7]
PMID 30524427 →Suppression of Intestinal Epithelial Cell Chemokine Production by Lactobacillus rhamnosus R0011 and Lactobacillus helveticus R0389 Is Mediated by Secreted Bioactive Molecules· Frontiers in Immunology · 2018
-
[8]
Source →Probiotic Lacidofil® STRONG Mitigates the Antibiotic‐Induced Alteration of the Fecal microRNA Signature in Healthy Humans· The FASEB Journal · 2016
-
[9]
Source →Experience using probiotic strains Lactobacillus acidophilus R0052 and Lactobacillus rhamnosus R0011 in children with burn injuriesДосвід використання пробіотичних штамів Lactobacillus acidophilus R0052 та Lactobacillus rhamnosus R0011 у дітей з опіковою травмою· GASTROENTEROLOGY · 2016
-
[10]
PMID 25692549 →Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) Reduce the Expression of Toll-Like Receptor 4 in Mice with Alcoholic Liver Disease· PLoS ONE · 2015